Evidence map›Paper›PMID 30279222›Full record

ArticleJournal of lipid research2018

Comprehensive shotgun lipidomics of human meibomian gland secretions using MS/MS

Jianzhong Chen, Kelly K Nichols

Erratum issuedAbstract read
In one paragraph

Article in Journal of lipid research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. A Novel Rat Model for Human Meibomian Gland Dysfunction and Ocular Rosacea.Investigative ophthalmology & visual science · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Changes in Human Meibum Lipid Composition Related to the Presence and Severity of Meibomian Gland Dysfunction.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Comparative Metabolomic Study ofInternational journal of molecular sciences · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Jianzhong ChenDepartment of Optometry and Vision Science, University of Alabama at Birmingham, Birmingham, AL 35294 jzchen@uab.edu.ORCID 0000-0001-5207-4798
Kelly K NicholsDepartment of Optometry and Vision Science, University of Alabama at Birmingham, Birmingham, AL 35294.ORCID 0000-0003-2937-1457

Funding

Visual Phenotyping CoreP30EY003039 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Paul Douglas Gamlin · 1985 to 2026
$16.9M
5500 Q-Trap Mass SpectrometerS10RR027822 · NCRR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BARNES, STEPHEN · 2010 to 2010
$469k
NCRR NIH HHS S10 RR027822NEI NIH HHS P30 EY003039
6 · The paper itself

Abstract

The lipid composition of human meibomian gland secretions (meibum) has been analyzed using both targeted and untargeted mass spectrometric approaches, each of which has its advantages and disadvantages. Herein we report the results of shotgun lipidomic profiling of human meibum using a new approach that combines the advantages of targeted and untargeted analyses to yield highly sensitive and comprehensive profiles. Samples containing an estimated 7-13 µg (8-16 nL) of human meibum lipids were analyzed using MS/MS

Indexed as

Cholesterol EstersFatty AcidsHumansMeibomian GlandsPhospholipidsTandem Mass SpectrometryTriglyceridesCholesterol EstersFatty AcidsPhospholipidsTriglyceridescholesteryl esterdiestereyefatty acidmass spectrometryphospholipidstriglycerides

Identifiers

PMID30279222
PMCPMC6210907

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.